Decibel Therapeutics Inc. (DBTX)

AI Score

Unlock

4.91

-0.04 (-0.81%)

At close: Sep 22, 2023, 8:00 PM

4.91

0.00%

After-hours: Sep 22, 2023, 04:11 PM EDT

Decibel Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-19.04M	-14.12M	-16.49M	-16.35M	-17.1M	-14.02M	-12.9M	-14.7M	-11.73M	-10.9M	-13.01M	-7.09M	-7.85M	-11.61M	-6.44M
Interest Income	976K	878K	660K	374K	95K	63K	52K	33K	75K	33K	-48K	2K	22K	79K	217K
Pretax Income	-18.07M	-13.24M	-15.83M	-15.97M	-17.01M	-13.96M	-12.84M	-14.67M	-11.65M	-10.87M	-12.88M	-7.11M	-7.81M	-11.54M	-6.22M
Net Income	-18.14M	-13.3M	-15.94M	-16M	-17.05M	-14.02M	-12.9M	-16.4M	-11.65M	-10.87M	-12.88M	-7.11M	-7.81M	-11.54M	-6.22M
Selling & General & Admin	6.21M	6.19M	4.89M	6.32M	5.86M	6.55M	4.92M	5.68M	4.9M	4.88M	5.11M	2.4M	2.56M	4.18M	3.26M
Research & Development	12.83M	7.93M	11.59M	10.03M	11.24M	7.47M	7.98M	9.02M	6.83M	6.02M	7.9M	4.69M	5.3M	7.44M	3.17M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-25K	25K	n/a	n/a
Operating Expenses	19.04M	14.12M	16.49M	16.35M	17.1M	14.02M	12.9M	14.7M	11.73M	10.9M	13.01M	7.09M	7.85M	11.61M	6.44M
Interest Expense	n/a	n/a	660K	374K	95K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	19.04M	14.12M	16.49M	16.35M	17.1M	14.02M	12.9M	14.7M	11.73M	10.9M	13.01M	7.09M	7.85M	11.61M	6.44M
Income Tax Expense	80K	61K	112K	30K	38K	60K	65K	1.73M	n/a	n/a	-345K	-2K	-22K	n/a	n/a
Shares Outstanding (Basic)	25.02M	24.99M	24.96M	24.96M	24.96M	24.96M	24.95M	24.87M	24.87M	12.11M	23.12M	7.36M	7.36M	7.36M	7.36M
Shares Outstanding (Diluted)	25.02M	24.99M	24.96M	24.96M	24.96M	24.96M	24.95M	24.87M	24.87M	12.11M	23.12M	7.36M	7.36M	7.36M	7.36M
EPS (Basic)	-0.73	-0.53	-0.64	-0.64	-0.68	-0.56	-0.52	-0.66	-0.47	-0.9	-0.56	-0.97	-1.06	-1.57	-0.85
EPS (Diluted)	-0.73	-0.53	-0.64	-0.64	-0.68	-0.56	-0.52	-0.66	-0.47	-0.9	-0.56	-0.97	-1.06	-1.57	-0.85
EBITDA	-18.72M	-13.78M	-16.11M	-15.99M	-16.74M	-13.65M	-12.59M	-14.36M	-11.39M	-10.48M	-13.01M	-6.69M	-7.44M	-11.13M	-5.88M
EBIT	n/a	-14M	-15.17M	-15.6M	-16.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	323K	340K	374K	359K	362K	367K	309K	340K	337K	427K	345K	394K	416K	487K	554K